Ananda Developments
Ananda Developments · page 2
- Markets & Stocks
German Cannabis Stocks Jump on Passage of Draft Adult-Use Bill, More from Jazz Pharma & Ananda Developments
German Stocks Spike on Passage of Draft Law [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”SBX.DE” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Synbiotic SE (SBX) Yesterday, the German federal cabinet officially passed the draft law which would seek to implement Pillar 1 of the country’s ambitious adult-use cannabis legalisation strategy.
- Medical
UK Medical Cannabis Industry Gathers Momentum Amid Numerous Research Milestones
The UK’s National Health Service (NHS) Research Ethics Committee this week approved the full-scale rollout of a new clinical trial into medical cannabis and non-cancer chronic pain.
- Markets & Stocks
Ananda Developments Set For Commercial Launch This Month, Dragonfly Biosciences To IPO Next Month, & More From MGC Pharma
Ananda Developments Aquis Stock Exchange-listed Ananda Developments has seen its stock jump by nearly 20% over the last week following the announcement that its MRX1 CBD oil is on track to launch commercially this month.
- Markets & Stocks
German Announcement Hits Stocks, Ananda Shares Skyrocket, & Futura Medical Launches Flagship Product In The UK
Last week’s announcement from the German Health Minister Dr Karl Lauterbach has seen the stock in a number of companies with significant operations in Germany take a hit.
- Companies
Ananda Developments Takes ‘Big Step’ Towards Revenues And Potential NHS Funding With £2m MRX Global Acquisition
ANANDA Developments has today announced the acquisition of MRX Global in a deal set to transform the company’s offering.
